Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future

过度诊断 医学 前列腺癌 前列腺癌筛查 癌症 人口 随机对照试验 肿瘤科 疾病 前列腺 妇科 内科学 前列腺特异性抗原 重症监护医学 环境卫生
作者
Hendrik Van Poppel,Tit Albreht,Partha Basu,Renée Hogenhout,Sarah Collen,Monique J. Roobol
出处
期刊:Nature Reviews Urology [Nature Portfolio]
卷期号:19 (9): 562-572 被引量:140
标识
DOI:10.1038/s41585-022-00638-6
摘要

In the pre-PSA-detection era, a large proportion of men were diagnosed with metastatic prostate cancer and died of the disease; after the introduction of the serum PSA test, randomized controlled prostate cancer screening trials in the USA and Europe were conducted to assess the effect of PSA screening on prostate cancer mortality. Contradictory outcomes of the trials and the accompanying overdiagnosis resulted in recommendations against prostate cancer screening by organizations such as the United States Preventive Services Task Force. These recommendations were followed by a decline in PSA testing and a rise in late-stage diagnosis and prostate cancer mortality. Re-evaluation of the randomized trials, which accounted for contamination, showed that PSA-based screening does indeed reduce prostate cancer mortality; however, the debate about whether to screen or not to screen continues because of the considerable overdiagnosis that occurs using PSA-based screening. Meanwhile, awareness among the population of prostate cancer as a potentially lethal disease stimulates opportunistic screening practices that further increase overdiagnosis without the benefit of mortality reduction. However, in the past decade, new screening tools have been developed that make the classic PSA-only-based screening an outdated strategy. With improved use of PSA, in combination with age, prostate volume and with the application of prostate cancer risk calculators, a risk-adapted strategy enables improved stratification of men with prostate cancer and avoidance of unnecessary diagnostic procedures. This combination used with advanced detection techniques (such as MRI and targeted biopsy), can reduce overdiagnosis. Moreover, new biomarkers are becoming available and will enable further improvements in risk stratification. In this Perspective, the authors discuss the past, present and future of PSA screening for the early detection of aggressive prostate cancer and propose a way forward for the rational use of PSA testing as part of a risk-adapted screening strategy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
赘婿应助lw777采纳,获得10
1秒前
2秒前
小蘑菇应助张大英采纳,获得10
2秒前
华仔应助2889580752采纳,获得10
4秒前
嘻嘻完成签到,获得积分10
4秒前
5秒前
丘比特应助科研通管家采纳,获得10
5秒前
领导范儿应助科研通管家采纳,获得10
5秒前
慕青应助科研通管家采纳,获得10
5秒前
5秒前
斯文败类应助科研通管家采纳,获得10
5秒前
5秒前
思源应助科研通管家采纳,获得10
5秒前
田様应助科研通管家采纳,获得10
5秒前
Volcano完成签到,获得积分10
5秒前
无花果应助俏皮的白柏采纳,获得10
6秒前
单薄的夜南应助宁学者采纳,获得10
6秒前
7秒前
7秒前
7秒前
8秒前
空禅yew发布了新的文献求助10
8秒前
华仔应助云辞忧采纳,获得10
10秒前
10秒前
Sunwenrui完成签到,获得积分10
10秒前
12完成签到,获得积分10
12秒前
whoami发布了新的文献求助10
13秒前
13秒前
搜集达人应助TTT0530采纳,获得10
14秒前
张大英发布了新的文献求助10
15秒前
15秒前
16秒前
tassssadar完成签到,获得积分10
16秒前
隐形曼青应助小猴子采纳,获得10
19秒前
20秒前
whoami完成签到,获得积分10
20秒前
Toong发布了新的文献求助10
20秒前
20秒前
20秒前
RR发布了新的文献求助10
21秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988868
求助须知:如何正确求助?哪些是违规求助? 3531255
关于积分的说明 11253071
捐赠科研通 3269858
什么是DOI,文献DOI怎么找? 1804822
邀请新用户注册赠送积分活动 881994
科研通“疑难数据库(出版商)”最低求助积分说明 809035